Telomerase activity in human intestine

International Journal of Oncology

Volumn 9, Issue 3, 1996, Pages 453-458

  Hiyama, Eiso ^a   Hiyama, Keiko ^a   Tatsumoto, Naokuni ^a   Kodama, Takashi ^a   Shay, Jerry W ^b   Yokoyama, Takashi ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

crypt; intestine; stem cells; telomerase; telomere

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CELL DIVISION; CELL PROLIFERATION; CHILD; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; INTESTINE; INTESTINE CRYPT; INTESTINE MUCOSA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; STEM CELL; TELOMERE;

EID: 0029829887     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.9.3.453     Document Type: Article

References (34)

1. Shay JW, Werbin H and Wright WE: Telomere shortening may contribute to aging and cancer: a perspective. Mol Cell Differ 2: 1-21, 1994.
2. Blackburn EH: Structure and function of telomeres. Nature 350: 569-573, 1991.
3. Blackburn EH: Telomeres: no end in sight. Cell 77: 621-623, 1994.
4. Watson JD: Origin of concatemeric T7 DNA. Nature New Biol 239: 197-201, 1972.
5. Shay JW: Aging and cancer: are telomeres and telomerase the connection? Mol Med Today 1: 378-384, 1995.
6. Feng J, Funk WD, Wang S-S, Weinrich SL, Avilion AA, Chiu C-P, Adams RR, Chang E, Allsopp RC, Yu J, Le S, West MD, Harley CB, Andrews WH, Greider CW and Villeponteau B: The RNA component of human telomerase. Science 269: 1236-1241, 1995.
7. Harley CB: Telomere loss: mitotic clock or genetic time bomb? Mutat Res 256: 271-282, 1991.
8. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PLC, Coviello GM, Wright WE, Weinrich SL and Shay JW: Specific association of human telomerase activity with immortal cells and cancer. Science 266: 2011-2015, 1994.
9. Piatyszek MA, Kim NW, Weinrich SL, Hiyama K, Hiyama E, Wright WE and Shay JW: Detection of telomerase activity in human cells and tumors by a telomeric repeat amplification protocol (TRAP). Methods Cell Sci 17: 1-15, 1995.
10. Hiyama E, Hiyama K, Yokoyama T, Matsuura Y, Piatyszek MA and Shay JW: Correlating telomerase activity levels with human neuroblastoma outcomes. Nature Med 1: 249-255, 1995.
11. Hiyama K, Hiyama E, Ishioka S, Yamakido M, Inai K, Gazdar AF, Piatyszek MA and Shay JW: Telomerase activity in small-cell and non-small-cell lung cancers. J Natl Cancer Inst 87: 895-902, 1995.
12. Chadeneau C, Hay K, Hirte HW, Gallinger S and Bacchetti S: Telomerase activity associated with acquisition of malignancy in human colorectal cancer. Cancer Res 55: 2533-2536, 1995.
13. Hiyama E, Yokoyama T, Tatsumoto N, Hiyama K, Imamura Y, Murakami Y, Kodama T, Piatyszek MA, Shay JW and Matsuura Y: Telomerase activity in gastric cancer. Cancer Res 55: 3258-3262, 1995.
14. Hiyama E, Gollahan L, Kataoka T, Kuroi K, Yokoyama T, Gazdar AF, Hiyama K, Piatyszek MA and Shay JW: Telomerase activity in human breast tumors. J Natl Cancer Inst 88: 116-122, 1996.
15. Counter CM, Avilion AA, LeFeuvre CE, Stewart NG, Greider CW, Harley CB and Bacchetti S: Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J 11: 1921-1929, 1992.
16. Counter CM, Hirte HW, Bacchetti S and Harley CB: Telomerase activity in human ovarian carcinoma. Proc Natl Acad Sci USA 91: 2900-2904, 1994.
17. De Lange T: Activation of telomerase in a human tumor. Proc Natl Acad Sci USA 91: 2882-2885, 1994.
18. Harley CB, Kim NW, Prowse KL, Weinrich SL, Hirsh KS, West MD, Bacchetti S, Hirte HW, Counter CM, Greider CW, Piatyszek MA, Wright WE and Shay JW: Telomerase, cell immortality, and cancer. Cold Spring Harbor Symp Quant Biol 59: 307-315, 1994.
19. Morin GB: Is telomerase a universal cancer target? J Natl Cancer Inst 87: 859-861, 1995.
20. Hiyama K, Hirai Y, Kyouizumi S, Akiyama M, Hiyama E, Piatyszek MA and Shay JW: Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J Immunol 155: 3711-3715, 1995.
21. Taylor RS, Ramirez RD, Ogoshi M, Chaffins M, Piatyszek MA and Shay JW: Detection of telomerase activity in malignant and nonmalignant skin condition. J Invest Dermatol 106: 756-765, 1996.
22. Podolsky DK: Regulation of intestinal epithelial proliferation: a few answers, many questions. Am J Physiol 264: 179-186, 1993.
23. Wright NA and Alison M: The biology of epithelial cell populations. Clarendon Press, Oxford, Vol 2, pp1-67, 1984.
24. Potten CS, Kellett M, Roberts SA, Rew DA and Wilson GD: Measurement of in vivo proliferation in human colorectal mucosa using bromodeoxyiridine. Gut 33: 71-78, 1992.
25. Wright WE, Shay JW and Piatyszek MA: Modification of a telomeric repeat amplification protocol (TRAP) result in increased reliability, linearity and sensitivity. Nucleic Acids Res 23: 3794-3795, 1995.
26. Hiyama E, Hiyama K, Yokoyama T, Ichikawa T and Matsuura Y: Length of telomeric repeats in neuroblastoma: correlation with prognosis and other biological characteristics. Jpn J Cancer Res 83: 159-164, 1992.
27. Hastie ND, Dempster M, Dunlop MG, Thompson AM, Green DK and Allshire RC: Telomere reduction in human colorectal carcinoma and with ageing. Nature 346: 866-868, 1990.
28. Harley CB, Futcher AB and Greider CW: Telomeres shorten during ageing of human fibroblasts. Nature 345: 458-460, 1990.
29. Lindsey J, McGill NI, Lindsey LA, Green DK and Cooke HJ: In vivo loss of telomeric repeats with age in humans. Mutat Res 256: 45-48, 1991.
30. Allsopp RC, Vaziri H, Patterson C, Goldstein S, Younglai EV, Futcher AB, Greider CW and Harley CB: Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci USA 89: 10114-10118, 1992.
31. Levy MZ, Allsopp RC, Futcher B, Greider CW and Harley CB: Telomere end-replication preoblem and cell aging. J Mol Biol 225: 951-960, 1992.
32. Vaziri H, Schachter F, Uchida I, Wei L, Zhu X, Effros R, Cohen D and Harley CB: Loss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes. Am J Hum Genet 52: 661-667, 1993.
33. Martin GM: Genetic modulation of telomeric terminal restriction-fragment length: relevance for clonal aging and late-life disease. Am J Hum Genet 55: 866-869, 1994.
34. Chang E and Harley CB: Telomere length and replicative aging in human vascular tissues. Proc Natl Acad Sci USA 92: 11190-11194, 1995.